The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-vitro Inflammatory Bowel Disease Diagnostic Market Research Report 2025
Synopsis
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
The global In-vitro Inflammatory Bowel Disease Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In-vitro Inflammatory Bowel Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Inflammatory Bowel Disease Diagnostic.
Report Scope
The In-vitro Inflammatory Bowel Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-vitro Inflammatory Bowel Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Inflammatory Bowel Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Inflammatory Bowel Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn’s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.
The global In-vitro Inflammatory Bowel Disease Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In-vitro Inflammatory Bowel Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Inflammatory Bowel Disease Diagnostic.
Report Scope
The In-vitro Inflammatory Bowel Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-vitro Inflammatory Bowel Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-vitro Inflammatory Bowel Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott
Quidel Corporation
American Laboratory Products Company (ALPCO)
Certest Biotec SL.
Biosystems S.A.
Segment by Type
Assays/Biomarker
Analyzers
Segment by Application
Diagnostic Laboratories
Hospitals
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Inflammatory Bowel Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Assays/Biomarker
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Perspective (2019-2030)
2.2 In-vitro Inflammatory Bowel Disease Diagnostic Growth Trends by Region
2.2.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Dynamics
2.3.1 In-vitro Inflammatory Bowel Disease Diagnostic Industry Trends
2.3.2 In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
2.3.3 In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
2.3.4 In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue
3.1.1 Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Revenue (2019-2024)
3.1.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-vitro Inflammatory Bowel Disease Diagnostic Revenue
3.4 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio
3.4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2023
3.5 In-vitro Inflammatory Bowel Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players In-vitro Inflammatory Bowel Disease Diagnostic Product Solution and Service
3.7 Date of Enter into In-vitro Inflammatory Bowel Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Type
4.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2025-2030)
5 In-vitro Inflammatory Bowel Disease Diagnostic Breakdown Data by Application
5.1 Global In-vitro Inflammatory Bowel Disease Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2019-2030)
6.2 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024)
6.4 North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2019-2030)
7.2 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024)
7.4 Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2019-2030)
9.2 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024)
9.4 Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DiaSorin S.p.A
11.1.1 DiaSorin S.p.A Company Detail
11.1.2 DiaSorin S.p.A Business Overview
11.1.3 DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.1.4 DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.1.5 DiaSorin S.p.A Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Detail
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Company Detail
11.3.2 Siemens Healthineers AG Business Overview
11.3.3 Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.3.4 Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.3.5 Siemens Healthineers AG Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.4.4 Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Quidel Corporation
11.5.1 Quidel Corporation Company Detail
11.5.2 Quidel Corporation Business Overview
11.5.3 Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.5.4 Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.5.5 Quidel Corporation Recent Development
11.6 American Laboratory Products Company (ALPCO)
11.6.1 American Laboratory Products Company (ALPCO) Company Detail
11.6.2 American Laboratory Products Company (ALPCO) Business Overview
11.6.3 American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.6.4 American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.6.5 American Laboratory Products Company (ALPCO) Recent Development
11.7 Certest Biotec SL.
11.7.1 Certest Biotec SL. Company Detail
11.7.2 Certest Biotec SL. Business Overview
11.7.3 Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.7.4 Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.7.5 Certest Biotec SL. Recent Development
11.8 Biosystems S.A.
11.8.1 Biosystems S.A. Company Detail
11.8.2 Biosystems S.A. Business Overview
11.8.3 Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Introduction
11.8.4 Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
11.8.5 Biosystems S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Assays/Biomarker
Table 3. Key Players of Analyzers
Table 4. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2019-2024)
Table 8. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2025-2030)
Table 10. In-vitro Inflammatory Bowel Disease Diagnostic Market Trends
Table 11. In-vitro Inflammatory Bowel Disease Diagnostic Market Drivers
Table 12. In-vitro Inflammatory Bowel Disease Diagnostic Market Challenges
Table 13. In-vitro Inflammatory Bowel Disease Diagnostic Market Restraints
Table 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players (2019-2024)
Table 16. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2023)
Table 17. Ranking of Global Top In-vitro Inflammatory Bowel Disease Diagnostic Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-vitro Inflammatory Bowel Disease Diagnostic Product Solution and Service
Table 21. Date of Enter into In-vitro Inflammatory Bowel Disease Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2019-2024)
Table 25. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Type (2025-2030)
Table 27. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2019-2024)
Table 29. Global In-vitro Inflammatory Bowel Disease Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global In-vitro Inflammatory Bowel Disease Diagnostic Revenue Market Share by Application (2025-2030)
Table 31. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. DiaSorin S.p.A Company Detail
Table 47. DiaSorin S.p.A Business Overview
Table 48. DiaSorin S.p.A In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 49. DiaSorin S.p.A Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 50. DiaSorin S.p.A Recent Development
Table 51. F. Hoffmann-La Roche Ltd Company Detail
Table 52. F. Hoffmann-La Roche Ltd Business Overview
Table 53. F. Hoffmann-La Roche Ltd In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 54. F. Hoffmann-La Roche Ltd Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 55. F. Hoffmann-La Roche Ltd Recent Development
Table 56. Siemens Healthineers AG Company Detail
Table 57. Siemens Healthineers AG Business Overview
Table 58. Siemens Healthineers AG In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 59. Siemens Healthineers AG Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 60. Siemens Healthineers AG Recent Development
Table 61. Abbott Company Detail
Table 62. Abbott Business Overview
Table 63. Abbott In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 64. Abbott Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Quidel Corporation Company Detail
Table 67. Quidel Corporation Business Overview
Table 68. Quidel Corporation In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 69. Quidel Corporation Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 70. Quidel Corporation Recent Development
Table 71. American Laboratory Products Company (ALPCO) Company Detail
Table 72. American Laboratory Products Company (ALPCO) Business Overview
Table 73. American Laboratory Products Company (ALPCO) In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 74. American Laboratory Products Company (ALPCO) Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 75. American Laboratory Products Company (ALPCO) Recent Development
Table 76. Certest Biotec SL. Company Detail
Table 77. Certest Biotec SL. Business Overview
Table 78. Certest Biotec SL. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 79. Certest Biotec SL. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 80. Certest Biotec SL. Recent Development
Table 81. Biosystems S.A. Company Detail
Table 82. Biosystems S.A. Business Overview
Table 83. Biosystems S.A. In-vitro Inflammatory Bowel Disease Diagnostic Product
Table 84. Biosystems S.A. Revenue in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 85. Biosystems S.A. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Assays/Biomarker Features
Figure 4. Analyzers Features
Figure 5. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Application: 2023 VS 2030
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. In-vitro Inflammatory Bowel Disease Diagnostic Report Years Considered
Figure 11. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region: 2023 VS 2030
Figure 14. Global In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Players in 2023
Figure 15. Global Top In-vitro Inflammatory Bowel Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Inflammatory Bowel Disease Diagnostic as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by In-vitro Inflammatory Bowel Disease Diagnostic Revenue in 2023
Figure 17. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2019-2030)
Figure 19. United States In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2019-2030)
Figure 23. Germany In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Region (2019-2030)
Figure 31. China In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2019-2030)
Figure 39. Mexico In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In-vitro Inflammatory Bowel Disease Diagnostic Market Share by Country (2019-2030)
Figure 43. Turkey In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia In-vitro Inflammatory Bowel Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. DiaSorin S.p.A Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 46. F. Hoffmann-La Roche Ltd Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 47. Siemens Healthineers AG Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 49. Quidel Corporation Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 50. American Laboratory Products Company (ALPCO) Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 51. Certest Biotec SL. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 52. Biosystems S.A. Revenue Growth Rate in In-vitro Inflammatory Bowel Disease Diagnostic Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
